2025-04-01 12:58:19
Latest Post
Man Industries monetizes its subsidiary's non-core asset in Prime Nerul Location, Navi Mumbai valued at ~₹720 Crores
InterGlobe Foundation and IndiGoReach organise 'My City My Heritage' Walk, showcasing Chhatrapati Sambhajinagar's Cultural Heritage
Relaxo Footwears Ltd honoured with SDG Achievers Award 2023-24 for Quality Education
KEC International wins New Orders of Rs. 1,236 crores
Newgen Software Technologies Ltd receives order worth Rs. 17.51 crore
Stock Report
Neuland Laboratories Q4 FY2021-22 consolidated profit jumps to Rs. 21.78 crores
Posted On : 2022-05-10 19:00:43( TIMEZONE : IST )
Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 256.5040 crores during the period ended March 31, 2022 as compared to Rs. 238.3699 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 21.7807 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 12.9356 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 16.97 for the period ended March 31, 2022 as compared to Rs. 10.08 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 256.5040 crs | ₹238.3699 crs |  7.61% |
| Net Profit | ₹21.7807 crs | ₹12.9356 crs | 68.38% |
| EPS | ₹16.97 | ₹10.08 | 68.35% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 256.5040 crores during the period ended March 31, 2022 as compared to Rs.259.3012 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.21.7807 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.17.2926 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.16.97 for the period ended March 31, 2022 as compared to Rs.13.48 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 256.5040 crs | ₹259.3012 crs |  -1.08% |
| Net Profit | ₹21.7807 crs | ₹17.2926 crs | 25.95% |
| EPS | ₹16.97 | ₹13.48 | 25.89% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.953.1534 crores during the Financial Year ended March 31, 2022 as compared to Rs.953.0082 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.63.8220 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.80.6307 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.49.74 for the Financial Year ended March 31, 2022 as compared to Rs.62.85 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹953.1534 crs | ₹953.0082 crs | 0.02% |
| Net Profit | ₹63.8220 crs | ₹80.6307 crs | -20.85% |
| EPS | ₹49.74 | ₹62.85 | -20.86% |
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 1229.35 as compared to the previous close of Rs. 1332.70. The total number of shares traded during the day was 12690 in over 2648 trades.
The stock hit an intraday high of Rs. 1425.00 and intraday low of 1188.00. The net turnover during the day was Rs. 16821526.00.
